3. Segment Information and Concentrations

12 Months Ended

Jun. 30, 2012

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (“Benchtop Laboratory Equipment Operations”), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments Operations”) and the design of bioprocessing systems and products and related royalty income (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
June 30, 2012:
Net Sales	$	4,160,500	$	1,940,900		$	101,200		$	—		$	6,202,600
Foreign Sales		2,505,300		884,000			3,600			—			3,392,900
Profit (Loss)		416,800		(190,400	)		(111,200	)		(78,500	)		36,700
Assets		2,366,100		1,083,400			822,800			1,499,900			5,772,200
Long-Lived Asset
Expenditures		30,700		49,500			1,018,000			—			1,098,200
Depreciation and Amortization		49,300		76,700			59,900			—			185,900

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Corporate and Other		Consolidated
June 30, 2011:
Net Sales	$	4,525,100	$	1,344,700		$	—	$	5,869,800
Foreign Sales		2,496,200		663,900			—		3,160,100
Profit (Loss)		584,400		(313,600	)		—		270,800
Assets		2,501,000		1,177,400			1,334,800		5,013,200
Long-Lived Asset
Expenditures		39,300		24,300			—		63,600
Depreciation and Amortization		56,000		132,400			—		188,400

During the year ended June 30, 2011, one customer accounted for approximately 11% of the Company’s total sales.

Certain information relating to the Company’s export sales follows:

		2012		2011
Export sales (principally Europe and Asia)	$	3,392,900	$	3,160,100